z-logo
open-access-imgOpen Access
CXCL13 Levels Indicate Treatment Responsiveness to Fingolimod in MS Patients
Author(s) -
Zerrin Karaaslan,
Murat Kürtüncü,
Halil İbrahim Akçay,
Tuncay Gündüz,
Burcu Altunrende,
Recai Türkoğlu,
Mefküre Eraksoy,
Canan Ulusoy,
Vuslat Yılmaz,
Erdem Tüzün
Publication year - 2021
Publication title -
european neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.573
H-Index - 77
eISSN - 1421-9913
pISSN - 0014-3022
DOI - 10.1159/000517770
Subject(s) - fingolimod , multiple sclerosis , medicine , psychology , physical medicine and rehabilitation , psychiatry

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom